AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Bid | 195 |
Market Cap | 16.54B |
Revenue (ttm) | - |
Net Income (ttm) | - |
EPS (ttm) | 8.98 |
PE Ratio (ttm) | 22.31 |
Forward PE | n/a |
Analyst | Buy |
Ask | 199.95 |
Volume | 1,684,950 |
Avg. Volume (20D) | 1,348,534 |
Open | 199.07 |
Previous Close | 217.99 |
Day's Range | 197.91 - 209.74 |
52-Week Range | 183.38 - 347.72 |
Beta | undefined |
About ICLR
ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It offers clinical development services, incl...
Analyst Forecast
According to 12 analyst ratings, the average rating for ICLR stock is "Buy." The 12-month stock price forecast is $280, which is an increase of 39.76% from the latest price.
Next Earnings Release
Analysts project revenue of $2.03B, reflecting a -1.75% YoY shrinking and earnings per share of 3.4, making a -1.73% decrease YoY.
2 months ago · seekingalpha.com
ICON Public Limited Company (ICLR) Q3 2024 Earnings Call TranscriptICON Public Limited Company (NASDAQ:ICLR ) Q3 2024 Earnings Conference Call October 24, 2024 8:00 AM ET Company Participants Kate Haven - Vice President of Investor Relations Steve Cutler - Chief Exec...